Skip to main content

Act Capital Management, Llc

Source: SEC Form 13F · as of Mar 2026

Act Capital Management, Llc holds 28 biotech & pharma companies tracked by BioSniper, totaling $66.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

28

Total value held

$66.4M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Krystal Biotech, Inc. (KRYS)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
KRYSKrystal Biotech, Inc.60,477$15.6M
TGTXTG THERAPEUTICS, INC.249,025$8.3M
ABVXAbivax SA70,900$7.9M
VKTXViking Therapeutics, Inc.209,300$6.8M
ARWRARROWHEAD PHARMACEUTICALS, INC.82,500$5.2M
NKTRNEKTAR THERAPEUTICS70,900$5.1M
CYTKCYTOKINETICS INC64,500$4.3M
ALMSALUMIS INC.174,250$3.8M
XENEXenon Pharmaceuticals Inc.33,500$1.9M
NUVBNuvation Bio Inc.290,000$1.2M
PRAXPraxis Precision Medicines, Inc.2,700$870K
KURAKura Oncology, Inc.73,900$601K
VIRVir Biotechnology, Inc.64,300$576K
SRRKScholar Rock Holding Corp10,800$531K
REPLReplimune Group, Inc.61,500$470K
RGNXREGENXBIO Inc.56,000$469K
PALIPALISADE BIO, INC.257,500$451K
OLMAOlema Pharmaceuticals, Inc.25,000$373K
GLUEMonte Rosa Therapeutics, Inc.22,500$370K
ACOGAlpha Cognition Inc.51,500$283K
MBXMBX Biosciences, Inc.9,000$269K
KYTXKyverna Therapeutics, Inc.30,000$259K
INCYIncyte Corp.2,000$188K
CAPRCAPRICOR THERAPEUTICS, INC.5,000$152K
ESPREsperion Therapeutics, Inc.47,500$130K
AMLXAmylyx Pharmaceuticals, Inc.9,000$125K
CMPSCOMPASS Pathways plc15,500$86K
PDSBPDS Biotechnology Corp30,000$18K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.